Bank of Montreal
VRCA icon

Bank of Montreal’s Verrica Pharmaceuticals VRCA Stock Holding History

Bank of Montreal’s Portfolio VRCA Stock Details VRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-30
Closed -$4K – 4926
2021
Q1 		$4K Sell
30
-158
-84% -$21.9K ﹤0.01% 4764
2020
Q4 		$21K Buy
188
+116
+161% +$10.7K ﹤0.01% 4404
2020
Q3 		$6K Sell
72
-25
-26% -$2.05K ﹤0.01% 4365
2020
Q2 		$8K Buy
+97
New +$11.2K ﹤0.01% 4286
2020
Q1 		– Sell
-164
Closed -$26K – 4758
2019
Q4 		$26K Buy
164
+51
+45% +$7.53K ﹤0.01% 4169
2019
Q3 		$17K Buy
113
+5
+5% +$557 ﹤0.01% 4182
2019
Q2 		$13K Buy
+108
New +$10.1K ﹤0.01% 4423
2019
Q1 		– Sell
-8
Closed -$1K – 4775
2018
Q4 		$1K Buy
8
+4
+100% +$486 ﹤0.01% 4566
2018
Q3 		$1K Buy
+4
New +$683 ﹤0.01% 4609

Other funds holding VRCA

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
FI
Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of Montreal's VRCA Position: Q2 2021 in Review

Bank of Montreal sold out of Verrica Pharmaceuticals (VRCA) in Q2 2021, closing a stake of 30 shares — an estimated $4K sold.

Bank of Montreal first reported a position in VRCA in Q3 2018 and held it in 9 quarters. The position peaked at $26K in Q4 2019. 53 funds tracked by Wall St. Rank hold VRCA as of Q2 2021.

  • Bank of Montreal reported no remaining Verrica Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 30 Verrica Pharmaceuticals shares in Q2 2021, an estimated $4K.
  • Bank of Montreal first reported a position in Verrica Pharmaceuticals in Q3 2018 and held it in 9 quarters.
  • Bank of Montreal's Verrica Pharmaceuticals position peaked at $26K in Q4 2019.
  • 53 funds tracked by Wall St. Rank held Verrica Pharmaceuticals as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.